The FDA expects to fully integrate its AI approach by June 30, though its different centers have been instructed to start the rollout immediately.

The FDA did not respond to a request for comment. U.S. Health Secretary Robert F. Kennedy Jr. has said that the agency's restructuring aims to streamline functions such as IT and communications, and reduce conflicts of interest among its staff and advisors.

Robert F. Kennedy Jr’s congressional hearing featured numerous statements from the secretary of HHS, including denouncing claims of cutting down the HHS and the National Institutes of Health.

On May 8, 2025, the Food and Drug Administration (FDA) announced the completion of its generative artificial intelligence (AI) pilot program

the current FDA staff member and a former FDA employee told NBC News. That review process ground to a halt after the Trump administration’s mass layoffs of federal health workers in early April, which gutted the teams responsible for reviewing public ...

In a surprise post this afternoon, new FDA Commissioner Dr Martin Makary announced a completed pilot at the FDA of a generative AI-based system for speeding up drug review - and plans to roll out the system across the agency by the end of June.

The Food and Drug Administration’s Center for Tobacco Products (CTP) has a new acting director, according to a Bloomberg report Thursday. FDA Commissioner Marty Makary said agency veteran Bret Koplow will be temporarily filling the role, Bloomberg reported, based on internal emails.

It saves lives," Michael Barasch, partner at Barasch & McGarry, a law firm representing thousands of first responders